PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast Apr 26, 2024 08:30AM
PaxMedica (PXMD) Responds to Emergency Request for IV Suramin, Commits to Provide Immediate Access to PAX-101 Apr 23, 2024 08:32AM
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 Apr 23, 2024 08:30AM
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 Apr 23, 2024 08:30AM
PaxMedica Releases Fireside Chat Video with CEO Howard Weisman Dec 6, 2023 08:00AM


Nov 17, 2023 08:00AM PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
Nov 15, 2023 06:50PM PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update
Nov 9, 2023 08:00AM PaxMedica's Chief Medical Officer Discusses FDA Meeting Highlights on The Bell2Bell Podcast
Nov 7, 2023 08:25AM PaxMedica (PXMD) Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal
Nov 7, 2023 08:00AM PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal
Oct 30, 2023 11:30AM PaxMedica (PXMD) Announces 1-for-17 Reverse Stock Split
Oct 30, 2023 11:30AM PaxMedica Announces 1-for-17 Reverse Stock Split
Oct 26, 2023 01:51PM PaxMedica's Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication
Oct 26, 2023 08:02AM PaxMedica (PXMD) Holds FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
Oct 26, 2023 08:00AM PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
Oct 18, 2023 10:10AM The Bell2Bell Podcast featuring Howard Weisman, CEO and Buzz Woods of PaxMedica, Inc. (Nasdaq: PXMD)
Oct 10, 2023 08:00AM PaxMedica Announces Gold Sponsorship of The BRAIN Foundation's Synchrony Symposia 2023